| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 22,595,000 | 20,498,000 | 18,449,000 | 17,108,000 | 14,351,000 |
| Sales Growth | +10.23% | +11.11% | +7.84% | +19.21% | -3.58% |
| Net Income | 2,993,000 | 3,165,000 | 2,358,000 | 1,994,000 | 1,599,000 |
| Net Income Growth | -5.43% | +34.22% | +18.25% | +24.70% | -23.24% |
Stryker Corp (SYK)
372.39 -1.88 (-0.50%) 14:37 ET [NYSE]
372.11 x 10 372.63 x 24
Realtime by (Cboe BZX)
372.11 x 10 372.63 x 24
Realtime 374.01 -0.26 (-0.07%) 07:14 ET
for Tue, Mar 25th, 2025
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Fiscal Year End Date: 12/31